Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LUXAU Stock Summary
In the News
LUXAU Financial details
Company Rating
Buy
Market Cap
0
Income
32.56M
Revenue
0
Book val./share
-0.44
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
17.2
Forward P/E
-
PEG
-0.01
P/S
-
P/B
1.05
P/C
-
P/FCF
-
Quick Ratio
0.02
Current Ratio
0.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.79
EPS next Y
-
EPS next Q
-
EPS this Y
-22556.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-61.11%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
1.54%
Inst Trans
0.76%
ROA
6%
ROE
6%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.87-10.41
52W High
-
52W Low
-
RSI
-
Rel Volume
0.02
Avg Volume
4.45K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
LUXAU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2020-12-31 | 2021-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.01 | 1.28 | |
Operating cash flow per share | -0.01 | 0 | |
Free cash flow per share | -0.01 | 0 | |
Cash per share | 8.01 | 0.01 | |
Book value per share | 7.74 | -0.64 | |
Tangible book value per share | 7.74 | 7.36 | |
Share holders equity per share | 7.74 | -0.64 | |
Interest debt per share | 0 | -0.66 | |
Market cap | 463.59M | 422.62M | |
Enterprise value | 462.96M | 422.21M | |
P/E ratio | -1.89K | 7.63 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -800.28 | -599.85K | |
PFCF ratio | -800.28 | -599.85K | |
P/B Ratio | 1.39 | -15.38 | |
PTB ratio | 1.39 | -15.38 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -1.89K | 15.58 | |
EV to operating cash flow | -799.18 | -599.25K | |
EV to free cash flow | -799.18 | -599.25K | |
Earnings yield | 0 | 0.13 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 2.61 | -0.02 | |
Current ratio | 5.71 | 0.71 | |
Interest coverage | 0 | 0.04 | |
Income quality | 2.37 | 0 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 0.99 | 4.29 | |
ROIC | 0 | 0.09 | |
Return on tangible assets | 0 | 0.16 | |
Graham Net | 7.73 | -0.64 | |
Working capital | 896.47K | -269.81K | |
Tangible asset value | 333.83M | 317.51M | |
Net current asset value | -11.18M | -27.51M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 138.12K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | -2.01 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
Metric | History | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0.16 | 0.06 | 0.23 | 0.36 | 0.14 | |
Operating cash flow per share | -0.01 | 0 | 0.01 | -0.01 | 0 | |
Free cash flow per share | -0.01 | 0 | 0.01 | -0.01 | 0 | |
Cash per share | 0.02 | 0 | 0.01 | 0 | 0 | |
Book value per share | 24.18 | -0.75 | -0.64 | -0.46 | -0.44 | |
Tangible book value per share | 24.18 | 7.25 | 7.36 | 7.54 | 9.56 | |
Share holders equity per share | 24.18 | -0.75 | -0.64 | -0.46 | -0.44 | |
Interest debt per share | 0 | 0 | -0.11 | -0.18 | -0.15 | |
Market cap | 126.82M | 423.06M | 422.63M | 425.21M | 341.21M | |
Enterprise value | 126.54M | 422.93M | 422.21M | 425.08M | 341.18M | |
P/E ratio | 15.76 | 40.03 | 10.82 | 6.87 | 18.19 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -914.56 | -2.81K | 856.18 | -1.47K | -3.3K | |
PFCF ratio | -914.56 | -2.81K | 856.18 | -1.47K | -3.3K | |
P/B Ratio | 0.41 | -13.08 | -15.38 | -21.38 | -22.4 | |
PTB ratio | 0.41 | -13.08 | -15.38 | -21.38 | -22.4 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 62.92 | 160.05 | 86.88 | 55.98 | 72.22 | |
EV to operating cash flow | -912.55 | -2.81K | 855.33 | -1.47K | -3.3K | |
EV to free cash flow | -912.55 | -2.81K | 855.33 | -1.47K | -3.3K | |
Earnings yield | 0.02 | 0.01 | 0.02 | 0.04 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.14 | -0.05 | -0.09 | -0.02 | -0.01 | |
Current ratio | 1.21 | 0.44 | 0.71 | 0.38 | 0.13 | |
Interest coverage | 0 | 0 | 0.01 | 0.04 | 0.09 | |
Income quality | -0.07 | -0.06 | 0.1 | -0.04 | -0.02 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.24 | 1.02 | 1.8 | 1.93 | 1.16 | |
ROIC | 0 | 0.01 | 0 | 0.03 | 0.03 | |
Return on tangible assets | 0.01 | 0.01 | 0.03 | 0.04 | 0.01 | |
Graham Net | -2.75 | -0.75 | -0.64 | -0.47 | -0.46 | |
Working capital | 84.47K | -242.1K | -269.81K | -547.62K | -1.05M | |
Tangible asset value | 310.01M | 312.65M | 317.51M | 325.11M | 329.8M | |
Net current asset value | -35M | -32.37M | -27.51M | -19.94M | -15.74M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 118.66K | 199.02K | 229.88K | 284.55K | 322.77K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.01 | -0.08 | -0.36 | -0.78 | -0.31 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
LUXAU Frequently Asked Questions
What is Lux Health Tech Acquisition Corp. stock symbol ?
Lux Health Tech Acquisition Corp. is a US stock , located in New york of Ny and trading under the symbol LUXAU
What is Lux Health Tech Acquisition Corp. stock quote today ?
Lux Health Tech Acquisition Corp. stock price is $- today.
Is Lux Health Tech Acquisition Corp. stock public?
Yes, Lux Health Tech Acquisition Corp. is a publicly traded company.